- Home
- LMFA vs EVAX Comparison
LMFA vs EVAX Comparison
Compare LMFA & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- EVAX
- Stock Information
- Founded
- LMFA 2008
- EVAX 2008
- Country
- LMFA United States
- EVAX Denmark
- Employees
- LMFA N/A
- EVAX N/A
- Industry
- LMFA Finance: Consumer Services
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LMFA Finance
- EVAX Health Care
- Exchange
- LMFA Nasdaq
- EVAX Nasdaq
- Market Cap
- LMFA 9.2M
- EVAX 8.7M
- IPO Year
- LMFA 2015
- EVAX 2021
- Fundamental
- Price
- LMFA $2.19
- EVAX $3.09
- Analyst Decision
- LMFA Hold
- EVAX Strong Buy
- Analyst Count
- LMFA 1
- EVAX 2
- Target Price
- LMFA N/A
- EVAX $11.00
- AVG Volume (30 Days)
- LMFA 91.6K
- EVAX 234.6K
- Earning Date
- LMFA 11-13-2024
- EVAX 10-31-2024
- Dividend Yield
- LMFA N/A
- EVAX N/A
- EPS Growth
- LMFA N/A
- EVAX N/A
- EPS
- LMFA N/A
- EVAX N/A
- Revenue
- LMFA $12,838,084.00
- EVAX $3,295,000.00
- Revenue This Year
- LMFA N/A
- EVAX $4,845.21
- Revenue Next Year
- LMFA N/A
- EVAX $30.30
- P/E Ratio
- LMFA N/A
- EVAX N/A
- Revenue Growth
- LMFA 27.81
- EVAX N/A
- 52 Week Low
- LMFA $1.84
- EVAX $3.05
- 52 Week High
- LMFA $6.11
- EVAX $68.05
- Technical
- Relative Strength Index (RSI)
- LMFA 44.22
- EVAX 26.28
- Support Level
- LMFA $1.84
- EVAX $3.17
- Resistance Level
- LMFA $2.55
- EVAX $3.90
- Average True Range (ATR)
- LMFA 0.20
- EVAX 0.58
- MACD
- LMFA 0.01
- EVAX 0.02
- Stochastic Oscillator
- LMFA 46.67
- EVAX 1.31
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.